Steward Partners Investment Advisory, LLC Intellia Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 1,530 shares of NTLA stock, worth $22,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,530
Previous 2,344
34.73%
Holding current value
$22,521
Previous $52,000
40.38%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$180 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$141 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$75.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$72.9 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.12B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...